GenSight Biologics S.A.
GSGTFOTCHealthcare● Active
$0.19
+$0.00(+0.00%)
Market Cap$30986300
P/E Ratio—
52W High$0.48
52W Low$0.1901
GenSight Biologics S.A.（GSGTF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GSGTF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00M | $1.50M | $1.27M | $2.58M | $5.28M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.00M | $1.50M | $1.27M | $2.58M | $5.28M |
| Gross Margin %(computed) | 100.04% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $6.44M | $12.37M | $19.36M | $18.94M | $22.55M |
| G&A Expenses | $2.54M | $3.58M | $6.50M | $8.01M | $5.68M |
| Total Operating Expenses | $11.06M | $17.31M | $30.96M | $30.42M | $33.40M |
| Operating Income | ($11.70M) | ($15.81M) | ($29.70M) | ($27.84M) | ($28.13M) |
| Operating Margin %(computed) | — | — | — | — | -533.09% |
| Interest Income | $0.00M | $0.00M | $0.00M | $2.65M | $0.00M |
| Interest Expense | $0.99M | $1.55M | $3.15M | $2.65M | $2.17M |
| Income Before Tax | ($12.04M) | ($13.98M) | ($27.92M) | ($27.62M) | ($28.61M) |
| Income Tax Expense | $0.00M | $0.02M | ($1.70M) | $0.01M | $0.00M |
| Net Income | ($12.03M) | ($14.00M) | ($26.22M) | ($27.62M) | ($28.62M) |
| Net Margin %(computed) | — | -933.40% | — | — | -542.40% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.08 | $-0.17 | $-0.54 | $-0.60 | $-0.63 |
| Wtd Avg Shares | 148.30M | 82.75M | 48.32M | 46.33M | 45.15M |
| EBITDA | ($11.24M) | ($11.37M) | ($20.89M) | ($26.77M) | ($27.20M) |
| EBITDA Margin %(computed) | — | -757.93% | — | — | -515.52% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · EUR · M
深入了解GenSight Biologics S.A.
关于GenSight Biologics S.A.（GSGTF）损益表
GenSight Biologics S.A.（GSGTF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，GSGTF实现营收$0.00B，毛利润$0.00B（毛利率100.04%），净利润($0.01B)（净利率-1203594.43%）。
常见问题
GSGTF · 4 问GenSight Biologics S.A.（GSGTF）2025财年营收为$0.00B，同比down99.9%。
GSGTF revenueGSGTF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09